Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience

por Varga, Zsuzsanna, Noske, Aurelia
Publicado 2015

Assessment of HER2 status in breast cancer: overall positivity rate and accuracy by fluorescence in situ hybridization and immunohistochemistry in a single institution over 12 year...

por Varga, Zsuzsanna, Noske, Aurelia, Ramach, Constanze, Padberg, Barbara, Moch, Holger
Publicado 2013

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

por Samartzis, Eleftherios P., Noske, Aurelia, Dedes, Konstantin J., Fink, Daniel, Imesch, Patrick
Publicado 2013

The G Protein-Coupled Estrogen Receptor (GPER) Is Expressed in Two Different Subcellular Localizations Reflecting Distinct Tumor Properties in Breast Cancer

por Samartzis, Eleftherios P., Noske, Aurelia, Meisel, Alexander, Varga, Zsuzsanna, Fink, Daniel, Imesch, Patrick
Publicado 2014

The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status

por Kruschewski, Martin, Mueller, Kathrin, Lipka, Sybille, Budczies, Jan, Noske, Aurelia, Buhr, Heinz Johannes, Elezkurtaj, Sefer
Publicado 2011

Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer

por Brandt, Simone, Samartzis, Eleftherios P., Zimmermann, Anne-Katrin, Fink, Daniel, Moch, Holger, Noske, Aurelia, Dedes, Konstantin J.
Publicado 2017

First prospective outcome data for the second-generation multigene test Endopredict in ER-positive/HER2-negative breast cancer

por Ettl, Johannes, Anders, Sophie-Isabelle, Hapfelmeier, Alexander, Paepke, Stefan, Noske, Aurelia, Weichert, Wilko, Klein, Evelyn, Kiechle, Marion
Publicado 2020

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study

por Samartzis, Nicolas, Samartzis, Eleftherios P, Noske, Aurelia, Fedier, André, Dedes, Konstantin J, Caduff, Rosmarie, Fink, Daniel, Imesch, Patrick
Publicado 2012

Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer

por Varga, Zsuzsanna, Sinn, Peter, Fritzsche, Florian, von Hochstetter, Arthur, Noske, Aurelia, Schraml, Peter, Tausch, Christoph, Trojan, Andreas, Moch, Holger
Publicado 2013

Correction: Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer

por Varga, Zsuzsanna, Sinn, Peter, Fritzsche, Florian, von Hochstetter, Arthur, Noske, Aurelia, Schraml, Peter, Tausch, Christoph, Trojan, Andreas, Moch, Holger
Publicado 2013

Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results

por Noske, Aurelia, Anders, Sophie-Isabelle, Ettl, Johannes, Hapfelmeier, Alexander, Steiger, Katja, Specht, Katja, Weichert, Wilko, Kiechle, Marion, Klein, Evelyn
Publicado 2019

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

por Vag, Tibor, Steiger, Katja, Rossmann, Andreas, Keller, Ulrich, Noske, Aurelia, Herhaus, Peter, Ettl, Johannes, Niemeyer, Markus, Wester, Hans-Jürgen, Schwaiger, Markus
Publicado 2018

Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover

por Denkert, Carsten, Budczies, Jan, Weichert, Wilko, Wohlgemuth, Gert, Scholz, Martin, Kind, Tobias, Niesporek, Silvia, Noske, Aurelia, Buckendahl, Anna, Dietel, Manfred, Fiehn, Oliver
Publicado 2008

Detection of CCNE1/URI (19q12) amplification by in situ hybridisation is common in high grade and type II endometrial cancer

por Noske, Aurelia, Brandt, Simone, Valtcheva, Nadejda, Wagner, Ulrich, Zhong, Qing, Bellini, Elisa, Fink, Daniel, Obermann, Ellen C., Moch, Holger, Wild, Peter J.
Publicado 2016

An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

por Noske, Aurelia, Schwabe, Michael, Weichert, Wilko, Darb-Esfahani, Silvia, Buckendahl, Ann-Christin, Sehouli, Jalid, Braicu, Elena I, Budczies, Jan, Dietel, Manfred, Denkert, Carsten
Publicado 2011

Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer

por Noske, Aurelia, Wagner, Daniel-Christoph, Schwamborn, Kristina, Foersch, Sebastian, Steiger, Katja, Kiechle, Marion, Oettler, Dirk, Karapetyan, Siranush, Hapfelmeier, Alexander, Roth, Wilfried, Weichert, Wilko
Publicado 2021

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

por Absmaier, Magdalena, Napieralski, Rudolf, Schuster, Tibor, Aubele, Michaela, Walch, Axel, Magdolen, Viktor, Dorn, Julia, Gross, Eva, Harbeck, Nadia, Noske, Aurelia, Kiechle, Marion, Schmitt, Manfred
Publicado 2018

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

por Lehmann, Annika, Denkert, Carsten, Budczies, Jan, Buckendahl, Ann-Christin, Darb-Esfahani, Silvia, Noske, Aurelia, Müller, Berit Maria, Bahra, Marcus, Neuhaus, Peter, Dietel, Manfred, Kristiansen, Glen, Weichert, Wilko
Publicado 2009

Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro

por Koppensteiner, Romana, Samartzis, Eleftherios P., Noske, Aurelia, von Teichman, Adriana, Dedes, Ioannis, Gwerder, Myriam, Imesch, Patrick, Ikenberg, Kristian, Moch, Holger, Fink, Daniel, Stucki, Manuel, Dedes, Konstantin J.
Publicado 2014

Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing – a case report

por Valtcheva, Nadejda, Lang, Franziska M., Noske, Aurelia, Samartzis, Eleftherios P., Schmidt, Anna-Maria, Bellini, Elisa, Fink, Daniel, Moch, Holger, Rechsteiner, Markus, Dedes, Konstantin J., Wild, Peter J.
Publicado 2017